Profit with us in the 2009 bear market
   

Key executives - Javelin Pharmaceuticals, Inc (JAV)

Name Age Position
Daniel B. Carr M.D. 60 Chief Exec. Officer, Chief Medical Officer
David Bernstein Esq. 46 Chief Intellectual Property Counsel, Corp. Sec. and Gen. Counsel
Fred H. Mermelstein Ph.D.   Pres, Director of IDDS
Rick Pierce   VP of Investor Relations
Stephen J. Tulipano CPA 49 Chief Financial Officer and Principal Accounting Officer